Advertisement

Topics

Bio Fund Management Limited Company Profile

17:21 EST 18th December 2018 | BioPortfolio

Bio Fund Management Oy Ltd (BioFund) is one of the leading European venture capital management companies investing solely in the Life Sciences. The main sectors of BioFund include Pharmaceuticals, Medical Technologies, Nutrition, and Environmental Technologies. BioFund has an international scope, with its main focus centered in Europe, especially in the Nordic countries. Its investors consist primarily of institutional investors. The company manages the Bio Fund Ventures I, II, III and BFV II Follow-on venture capital funds, whose combined commitments total EUR 195 million. The funds' investors consist primarily of domestic insurance companies, pension funds and foundations, and the European Investment Fund. BioFund's organisation has more than 100 years of experience in various life sciences sectors, including more than 30 years' experience in venture capital management. The team also include seasoned professionals from the finance industry, investment banking and institutional investing. The members of the team have been involved in the development of more than 50 life sciences companies as venture capitalists and/or entrepreneurs

Location

Mikonkatu,4 3rd Floor P.O.Box 164
Helsinki
FIN-00101
Finland

Contact

Phone: 358 (0) 9 2514 460
Fax: 358 (0) 9 2514 4620
Email: biofund@biofund.fi


News Articles [504 Associated News Articles listed on BioPortfolio]

Fagron NV : Disclosure of received notification

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 31 July 2018 - 7:00am (CET) Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major sha...

MorphoSys: Ausbau des Short-Engagements von Capital Fund Management

Martinsried (www.aktiencheck.de) - Leerverkäufer Capital Fund Management SA hebt Netto-Leerverkaufsposition in MorphoSys-Aktien leicht aus: Die Leerverkäufer von Capital Fund Management SA haben ih....

MorphoSys: Spürbarer Rückzug von Leerverkäufer Capital Fund Management setzt sich fort

Martinsried (www.aktiencheck.de) - Leerverkäufer Capital Fund Management SA baut Netto-Leerverkaufsposition in MorphoSys-Aktien spürbar aus: Die Leerverkäufer von Capital Fund Management SA befinde...

MorphoSys: Rückzug von Leerverkäufer Capital Fund Management setzt sich fort

Martinsried (www.aktiencheck.de) - Leerverkäufer Capital Fund Management SA senkt Netto-Leerverkaufsposition in MorphoSys-Aktien wieder signifikant: Die Leerverkäufer von Capital Fund Management SA....

MorphoSys: Leerverkäufer Capital Fund Management setzt Rückzug deutlich fort

Martinsried (www.aktiencheck.de) - Leerverkäufer Capital Fund Management SA reduziert Netto-Leerverkaufsposition in MorphoSys-Aktien signifikant: Die Leerverkäufer von Capital Fund Management SA se....

MorphoSys: Leerverkäufer Capital Fund Management im Attacke-Modus

Martinsried (www.aktiencheck.de) - Leerverkäufer Capital Fund Management SA baut Netto-Leerverkaufsposition in MorphoSys-Aktien etwas aus: Die Leerverkäufer von Capital Fund Management SA befinden ....

TwentyFour Select Monthly Income Fund - Issue of Equity

27 November 2018 TWENTYFOUR SELECT MONTHLY INCOME FUND LIMITED (a non-cellular company limited by shares incorporated in the Island of Guernsey under the Companies (Guernsey) Read more...

MorphoSys: Leerverkäufer Capital Fund Management hat sich wieder stark zurückgezogen

Martinsried (www.aktiencheck.de) - Leerverkäufer Capital Fund Management SA hat Netto-Leerverkaufsposition in MorphoSys-Aktien weiter stark abgebaut: Die Leerverkäufer von Capital Fund Management S....

PubMed Articles [1840 Associated PubMed Articles listed on BioPortfolio]

UK newspaper reporting of the NHS cancer drugs fund, 2010 to 2015: a retrospective media analysis.

Objective We wished to explore how UK national newspapers had covered the creation and operation of the Cancer Drugs Fund from 2010 to 2015. This was introduced to provide cancer patients in England w...

The Psychiatric Neuromodulation Unit: Implementation and Management.

The proven effectiveness of neuromodulation and stimulation techniques for the management of psychiatric disorders has brought strongly needed innovation in psychiatry, given the high prevalence and h...

Concerning A Service Commitment to Fund Your Medical Education.

Core competencies for the emerging specialty of pain psychology.

The Institute of Medicine (IOM) has reported that approximately 100 million Americans experience chronic pain. The IOM report on pain and the subsequent National Pain Strategy (NPS) issued by the U.S....

NASN 2018 Endowment Fund-Raising Activities.

Clinical Trials [2642 Associated Clinical Trials listed on BioPortfolio]

Stivarga Real Life Evidence in Hungary

The study aims to evaluate use of regorafenib in clinical practice in Hungary. The study should provide information about clinical characteristics of Hungarian regorafenib patients as well...

Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab Model

Background and Aims: The prevalence of hepatitis C virus infection (HCV) infection in Punjab, India is 3.29%, with an estimated burden of around 650,000 viremic chronic HCV (CHC) patients....

Effectiveness Study During the First 1,000 Days in Kenya

Malnutrition is a public health problem in Kenya, with 26% of children underfive years of age stunted, and 26% of pre-school children, 26% of women of reproductive age and 42% of pregnant ...

Cluster Randomized, Parallel-group, Prospective, Follow-up Effectiveness Study in Kenyan Children 6-35 Months

Malnutrition is a public health problem in Kenya, with 26% of children under-five years of age stunted, and 26% of pre-school children, 26% of women of reproductive age and 42% of pregnant...

Hepatitis C Self-Management

The objective of this study is to compare the efficacy of a 6-session hepatitis C self-management workshop to a hepatitis C self-management self-study program. Both interventions are desig...

Companies [1786 Associated Companies listed on BioPortfolio]

BioPharma Fund

BioPharma Fund is an investment fund that invests in shares of medical biotechnology companies. Biotechnology companies are developing new drugs for many diseases such as cancer, heart disease, diabet...

Voce Capital Management LLC

Voce Capital Management LLC is an employee-owned investment manager and the adviser to Voce Catalyst Partners LP (the “Fund”). The Fund is a long/short equity investment...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Battelle Ventures

Battelle Ventures, L.P., and its affiliate fund, Innovation Valley Partners (IVP), have a combined $255 million under management for creating and accelerating the development of e...

JDRF T1D Fund

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund accelerating life changing solutions to treat, prevent, and cure type 1 diabetes (T1D) through catalytic ...

More Information about "Bio Fund Management Limited" on BioPortfolio

We have published hundreds of Bio Fund Management Limited news stories on BioPortfolio along with dozens of Bio Fund Management Limited Clinical Trials and PubMed Articles about Bio Fund Management Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bio Fund Management Limited Companies in our database. You can also find out about relevant Bio Fund Management Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Corporate Database Quicklinks



Searches Linking to this Company Record